Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

Table 4 Cost per QALY from societal perspective

GBS carrier	% of meningitis cases with long-term sequelae
Prevalence	22.5%	35%	47.5%	60%
0.2000	222,459	152,325	86,209	24,031
0.2525*	117,993	63,072	10,641	cs
0.3000	71,705	23,138	cs	cs

ISSN: 2045-4015